Northern Trust’s Akoya BioSciences AKYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-83,490
| Closed | -$109K | – | 4428 |
|
|
2025
Q2 | $109K | Sell |
83,490
-147,730
| -64% | -$178K | ﹤0.01% | 4092 |
|
|
2025
Q1 | $321K | Sell |
231,220
-19,123
| -8% | -$41.9K | ﹤0.01% | 3768 |
|
|
2024
Q4 | $573K | Buy |
250,343
+39,799
| +19% | +$105K | ﹤0.01% | 3609 |
|
|
2024
Q3 | $573K | Buy |
210,544
+827
| +0.4% | +$2.02K | ﹤0.01% | 3545 |
|
|
2024
Q2 | $491K | Buy |
209,717
+2,322
| +1% | +$7.41K | ﹤0.01% | 3518 |
|
|
2024
Q1 | $973K | Sell |
207,395
-12,281
| -6% | -$63.8K | ﹤0.01% | 3318 |
|
|
2023
Q4 | $1.07M | Buy |
219,676
+35,928
| +20% | +$149K | ﹤0.01% | 3294 |
|
|
2023
Q3 | $854K | Buy |
183,748
+28,552
| +18% | +$164K | ﹤0.01% | 3348 |
|
|
2023
Q2 | $1.15M | Buy |
155,196
+24,227
| +18% | +$162K | ﹤0.01% | 3304 |
|
|
2023
Q1 | $1.07M | Buy |
130,969
+1,370
| +1% | +$14.3K | ﹤0.01% | 3197 |
|
|
2022
Q4 | $1.24M | Sell |
129,599
-1,986
| -2% | -$24.4K | ﹤0.01% | 3187 |
|
|
2022
Q3 | $1.55M | Buy |
131,585
+14,003
| +12% | +$184K | ﹤0.01% | 3143 |
|
|
2022
Q2 | $1.51M | Buy |
117,582
+12,198
| +12% | +$126K | ﹤0.01% | 3202 |
|
|
2022
Q1 | $1.16M | Sell |
105,384
-3,555
| -3% | -$41.2K | ﹤0.01% | 3356 |
|
|
2021
Q4 | $1.67M | Buy |
108,939
+38,186
| +54% | +$500K | ﹤0.01% | 3314 |
|
|
2021
Q3 | $988K | Sell |
70,753
-7,347
| -9% | -$123K | ﹤0.01% | 3561 |
|
|
2021
Q2 | $1.51M | Buy |
+78,100
| New | +$1.61M | ﹤0.01% | 3434 |
|
Northern Trust's AKYA Position: Q3 2025 in Review
Northern Trust sold out of Akoya BioSciences (AKYA) in Q3 2025, closing a stake of 83,490 shares — an estimated $109K sold.
Northern Trust first reported a position in AKYA in Q2 2021 and held it in 17 quarters. The position peaked at $1.67M in Q4 2021. 0 funds tracked by Wall St. Rank hold AKYA as of Q3 2025.
- Northern Trust reported no remaining Akoya BioSciences position as of Q3 2025 after selling out during the quarter.
- Northern Trust sold 83,490 Akoya BioSciences shares in Q3 2025, an estimated $109K.
- Northern Trust first reported a position in Akoya BioSciences in Q2 2021 and held it in 17 quarters.
- Northern Trust's Akoya BioSciences position peaked at $1.67M in Q4 2021.
- 0 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2025.
Based on Northern Trust's 13F filing for Q3 2025, filed 14 Nov 2025.